Retinol, AHA, and BHA around aesthetic procedures: how to adjust home care

"How many days before a procedure should I stop retinol?"

This is the home-care question we hear most often in consultation. Online, fixed numbers circulate—"three days before," "one week before," "two weeks before"—but you cannot apply the same number to every product and every procedure.

What to confirm first is not a calendar date but four pieces of information: whether the product is a cosmetic or a prescription, whether it is retinol, AHA, or BHA, the application area and frequency, and the planned procedure type and how much surface stimulation it involves. Once these four axes are clear, pause, continue, and restart guidance becomes concrete. Cellinique Clinic — a 10-minute walk from Apgujeong Station, at 228 Dosan-daero — summarizes the order we walk through in consultation.

3-line summary

1. Before fixed pause days, align product type · ingredient · area/frequency · procedure type — four factors.
2. For AHA products, FDA labeling guidance links increased sun sensitivity and sun-protection recommendations. Do not stop at sunscreen alone; share your exposure plan as well.
3. Restart is checked in three windows — surface status · remaining irritation · procedure instructions — more than by a single calendar number.

1. Do not treat retinol, AHA, and BHA as one bundle

All three ingredients appear in "exfoliation and texture" routines, but the consultation questions differ. Rather than naming an ingredient and only asking whether to stop, prepare the split below so guidance moves faster.

Ingredient	Common forms	What we especially confirm in consultation
Retinol / retinoids	Serum, cream, prescription ointment	Cosmetic vs prescription, labeled strength if present, last use date
AHA	Toner, peeling pad, serum	Acid name (e.g. glycolic), frequency, recent stinging or peeling
BHA	Toner, serum, spot treatment	Application area (full face vs local), whether used for acne management

Even under the same word "retinol," a low-strength cosmetic and a prescription retinoid are adjusted differently. Even under the same AHA label, a once-weekly pad and a daily toner produce different skin responses. So write ingredient name + form + frequency as one set. When you only say "I use retinol," the team still has to reconstruct concentration class, leave-on vs rinse-off form, and how long the product has been in your routine—details that change pause and restart advice. Bringing the three fields together shortens that reconstruction and reduces guesswork on both sides of the consult desk.

If you rotate products by season or switch brands often, note the current bottle you are actually using in the two weeks before the procedure, not an old product you stopped months ago. The recent pattern is what matters for surface status on the treatment day.

2. Record five items before consultation

You do not need an elaborate spreadsheet. Five notes in your phone are enough.

Item to record	What to write	Why it is needed
① Product info	Product name or label photo; whether full INCI is visible	Ingredient name alone does not reveal form or strength
② Application range	Full face / local / neck or hands, etc.	Overlap with the treatment zone
③ Frequency	Daily / 2–3× per week / occasional	Estimate of irritation load
④ Last use	Date and time of last application	Interval from procedure day
⑤ Recent response	Stinging, redness, peeling, dryness—and when it started	Current barrier status

A single label photo is often more accurate than a name copied by hand. Even when toner, pads, serum, and cream are mixed, photos let us match ingredients during consultation. If packaging is in another language, photograph the ingredient panel as well as the front label so acid names and retinoid wording are readable. For multi-step routines, one photo of the morning shelf and one of the evening shelf is usually enough to reconstruct order without you rewriting every product from memory under time pressure.

Also mark which products you would be unwilling to pause without a clear reason—especially prescription agents—so the conversation can separate optional cosmetic actives from medicines that need dual-clinician coordination.

3. View AHA and sun exposure on the same line

Fact check — evidence level: regulatory guidance document

The U.S. Food and Drug Administration (FDA) guidance on labeling cosmetics containing alpha hydroxy acids (AHAs) explains that topical AHAs can increase skin sensitivity to sunlight during use and for a period after use stops. It also recommends sun protection, clothing, and limited exposure accordingly.
This document is cosmetic labeling guidance; it is not a table of fixed pause days before individual procedures. Procedure plans are aligned in consultation using product, skin, and treatment information. (Source: U.S. Food and Drug Administration, labeling guidance for cosmetics containing alpha hydroxy acids)

In practice we hold three points together: from when and which sun protection you will use, whether outdoor activity, exercise, or travel exposure is planned, and how surface status after the procedure will be matched to protection methods. Post-procedure sun care is covered in our post-treatment sun protection guide; everyday habits are in our daily sunscreen use guide.

If AHA pads or leave-on toners are part of your current week, say so even if you plan to pause them before the visit. Recent use can still matter for how your skin responds to light and heat in the days around treatment. Share travel, outdoor sports, and long commute exposure the same way you share product names—those plans sit on the same decision line as the ingredient list.

4. Put photosensitivity risk on the list as well

Fact check — evidence level: regulatory guidance document

The FDA consumer page on the sun and your medicine explains that some medicines and topical products can be associated with photosensitivity (a sensitive response to sunlight). It is consumer guidance that certain ingredient and product groups require care with sun exposure.
Whether a specific product applies, and how to adjust the routine before and after a procedure, is confirmed in consultation using your full list of oral and topical products. (Source: U.S. Food and Drug Administration, The Sun and Your Medicine)

So rather than ending with home-care actives alone, bring oral medicines, dietary supplements, and prescription topicals as one list so the judgment range is wider. If you are considering energy-based procedures (laser, lifting devices, and similar), mention photosensitivity-related information in advance.

Photosensitivity questions are not limited to AHA. Some oral agents and other topicals appear in the same consumer guidance category. Listing everything you take or apply—even products you consider "only for another condition"—helps the team avoid adjusting one active while missing another that also changes sun response. If a specialist outside aesthetics manages a prescription, note who prescribed it so dual guidance is possible without guessing.

5. Prescription products and cosmetics follow different adjustment paths

Prescription retinoids and other prescribed skin medicines are not handled the same way as cosmetics. Do not change dose or frequency—or stop on your own—only because a procedure is coming. Instead, tell both the prescribing clinician and the procedure clinician the product name and how you use it, then follow their guidance.

For cosmetic retinol, AHA, and BHA as well, do not set a restart day from a "gentle" marketing line alone. The product range written in procedure instructions comes first; if instructions are unclear, ask specifically which product on which area.

Category	Adjustment principle	What to bring to consultation
Prescription products	No self-change; confirm with both clinicians	Prescription name, dose/frequency, treatment purpose
Over-the-counter cosmetics	Procedure instructions + current skin response	Label, frequency, last use, irritation status
Using both	Map overlapping areas and order first	Full AM/PM routine photo or list

When two or more actives stack in the morning or evening, it is safer around procedures to reduce or restart one at a time. Changing several products at once makes it hard to tell which one caused irritation. If your routine already layers retinol at night and an acid toner on alternate nights, write that alternation clearly—frequency is not only "how many nights per week" but also how products share the same week. Dual-path guidance (prescriber + procedure team) is especially important when a prescription retinoid sits under cosmetic acids in the same calendar week.

6. Split before, day-of, and after into three windows

Home-care adjustment, like recovery, is easier to schedule when you ask in three windows.

Window	What to check in home care	Impact on your calendar
Before the procedure	Continue vs pause guidance for actives; last use time	Back-calculating procedure day; surface status
Procedure day	Products used that morning; makeup and sunscreen allowed or not	Total time that day; plans after you go home
After the procedure	Restart order, sun protection, contact thresholds if irritated	Routine for the next 1–2 weeks; major events

If you have an important photo shoot or event, share that date first and look at a 4–6 week horizon together. Back-calculate the procedure day and home-care transition points with buffer built in.

Write the three windows next to your product list before you book. "What I used last night," "what I may apply on the morning of treatment," and "what I will wait to restart" are different questions; answering them in one vague sentence usually creates a gap later. Pair the windows with your outdoor and travel plans so sun-protection steps and active-restart steps do not collide on the same weekend.

Two steps used when restarting

Restart usually makes fewer mistakes when you use two steps. Step 1 is a window that checks whether the surface settles with barrier care and sun protection alone. Step 2 is a window that reintroduces actives at low frequency under clinician guidance. If stinging, redness, or peeling remains, contact us before you increase frequency.

When you receive restart guidance, keep it in writing: which product starting on which area, how many times per week at first, and whom to contact if irritation remains. Rather than only asking "Can I use it again?," share remaining reactions and last-use information together. A written two-step plan also helps if you travel or see another clinician in the same period—anyone reviewing your notes can see that barrier care came first and that actives were not restarted as a single all-or-nothing switch.

7. Focus points differ by procedure type

The same home-care table is hard to apply to every procedure. Even by category, the questions change.

Procedure category	What home care focuses on especially
Injectables (skin boosters and similar)	Overlap between treatment zones and active application range; day-of irritation
Energy-based (lifting, laser)	Restart timing after surface heat or stimulation; photosensitivity and sun plan
Combined schedules	Whether intervals between procedures clash with active restart or pause

For a combined plan, ask once whether the day- or week-scale intervals between procedures and the home-care transitions fit together. Separate instructions per procedure often tangle the calendar. If one session is injectable and the next is energy-based, the stricter sun or surface rule usually sets the shared buffer—confirm which rule leads rather than averaging two different handouts on your own.

Category labels are a starting map only. Your exact product list and surface status still decide the final pause and restart order inside that category.

8. Signals that need contact

Expected-range dryness or mild redness is different from changes that need contact. Pain that keeps getting worse over time, heat or redness spreading widely, blisters, discharge, sudden swelling, or systemic signs such as shortness of breath or widespread rash are contact triggers—do not assume they are only a product issue before you reach out.

Contact criteria are easiest to use when you receive them on a time axis: what to check the same day, what to watch over 2–3 days, and what still present after a week should prompt a call. General observation points are on our treatment safety page.

Save the after-hours route with the daytime number. When a change appears in the evening after you restarted an acid or retinoid, you should not have to search again for how to reach the clinic. Write the contact path next to your two-step restart plan so the document stays usable when you need it.

9. Consultation checklist

□ Did you prepare product labels or full-ingredient photos
□ Did you write application area, frequency, and last use date
□ Did you record recent stinging, redness, or peeling
□ Did you state whether products are prescription and who prescribed them
□ Did you list retinol, AHA, and BHA separately
□ Did you share sun-exposure plans (outdoor time, travel, exercise)
□ Did you receive home-care guidance for each of the three windows — before, day-of, and after
□ Did you receive restart order (two steps) and irritation contact paths in writing
□ Did you cross-check the next 4–6 weeks of plans

Nine items can look long, but the core is three: product photos + last use date + calendar. With those, consultation can fill in the rest. If any box stays empty when you leave, ask again before you rely on a generic online pause number—that number will not know your prescription status, your last acid night, or your outdoor week.

Frequently asked questions

Q1. How many days before a procedure should I stop retinol?

A single number for everyone is hard to give. Guidance changes with four factors: cosmetic vs prescription, strength and frequency, procedure type, and current skin response. Bring those details instead of a fixed day count, and you get a plan scaled to you.

Q2. Are AHA and BHA adjusted the same way?

They are hard to treat as identical from the name alone. AHA is especially reviewed together with sun sensitivity under FDA labeling guidance, while BHA questions often turn on whether use is full-face or local. Show label, frequency, and irritation for each.

Q3. If I use AHA, do I need to be more careful in the sun?

FDA AHA cosmetic labeling guidance explains that sun sensitivity can increase during use and for a period after stopping, and recommends sun protection, clothing, and limited exposure. Do not only pack sunscreen—align the exposure plan itself in consultation. Everyday protection tips are in our daily sunscreen use guide.

Q4. Can I pause a prescription retinoid on my own first?

Rather than changing dose or frequency only because of a procedure date, tell both the prescribing clinician and the procedure clinician the product name and how you use it, then follow guidance. The original treatment purpose and the procedure plan need to be aligned together.

Q5. If my skin stings after a procedure, can I layer several soothing products?

Adding many products at once makes it hard to identify the cause. Stay within one or two products in the guided range, and if irritation remains or worsens, contact us before adding new products.

Q6. Should I apply sunscreen on the morning of the procedure?

Guidance depends on procedure type and same-day protocol. When you confirm the booking, ask specifically which products are allowed that morning, and keep aftercare sun methods together with our post-treatment sun protection guide.

Q7. How many days after a procedure can I restart actives?

Surface status and written instructions matter more than a single calendar day. We usually split step 1 (barrier and protection) → step 2 (actives at low frequency), and check remaining irritation before increasing frequency. A written plan for the next 1–2 weeks reduces confusion.

Consultation information

Cellinique Clinic is at Yeonseung Building, 228 Dosan-daero, Gangnam-gu, Seoul — about a 10-minute walk from Apgujeong Station or Hakdong Station. Medical Director Dr. Kim Gun-woo handles consultation, treatment, and aftercare directly. Combinations of home-care ingredient lists and procedure plans are confirmed individually in consultation. General safety items are on our treatment safety page.

This article is general information and does not replace medical care. Diagnosis and plans suited to your condition should be confirmed in consultation.